Epidemiological studies support that the IGF pathway plays an important role in breast cancer risk, and a link between IGF signaling and breast cancer initiation is supported mechanistically by studies using IGF-1 transgenic mice. The gene discussed is IGF1; the disease is breast carcinoma.